Michael Wang Selected Research

Michael Wang Research Topics

Disease

91	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2024 - 02/2005
65	Neoplasms (Cancer) 07/2023 - 05/2003
52	Multiple Myeloma 01/2020 - 10/2003
26	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 02/2005
22	Hemorrhage 05/2024 - 05/2003
21	Hemophilia A (Haemophilia) 04/2024 - 01/2013
19	Lymphoma (Lymphomas) 01/2024 - 02/2005
13	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2023 - 10/2004
9	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 02/2005
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 05/2013
8	Infections 04/2024 - 07/2003
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 02/2005
7	Disease Progression 07/2023 - 10/2010
7	Thrombosis (Thrombus) 10/2021 - 01/2002
5	Body Weight (Weight, Body) 01/2023 - 05/2016
5	Pain (Aches) 07/2022 - 11/2006
5	Congenital Abnormalities (Deformity) 12/2021 - 10/2015
5	Venous Thromboembolism 10/2012 - 11/2007
4	Peripheral Nervous System Diseases (PNS Diseases) 05/2014 - 06/2009
3	Hemophilia B (Haemophilia B) 01/2024 - 11/2020
3	Necrosis 07/2023 - 01/2002
3	Residual Neoplasm 01/2023 - 01/2019
3	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 11/2006
3	Thrombophilia 10/2021 - 06/2013
3	Dehydration (Water Stress) 01/2020 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2007
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 10/2010
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 11/2011
3	Carcinogenesis 01/2018 - 05/2003
3	Thrombocytopenia (Thrombopenia) 01/2017 - 10/2012
3	Neutropenia 01/2017 - 11/2007
3	Brain Neoplasms (Brain Tumor) 11/2013 - 05/2007
3	Venous Thrombosis (Deep-Vein Thrombosis) 06/2013 - 02/2011
2	von Willebrand Diseases (von Willebrand's Disease) 05/2024 - 01/2022
2	Inflammation (Inflammations) 11/2023 - 10/2021
2	Glioma (Gliomas) 07/2023 - 07/2023
2	Prostatic Neoplasms (Prostate Cancer) 07/2023 - 07/2011
2	Hypersensitivity (Allergy) 07/2022 - 11/2021
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022 - 06/2015

Drug/Important Bio-Agent (IBA)

27	ibrutinibIBA 01/2024 - 06/2013
26	Rituximab (Mabthera)FDA Link 01/2023 - 10/2005
24	Lenalidomide (CC 5013)FDA Link 01/2023 - 10/2007
24	Bortezomib (Velcade)FDA Link 11/2019 - 02/2005
23	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 09/2014
18	Chimeric Antigen ReceptorsIBA 12/2023 - 01/2016
17	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 10/2003
15	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2003
14	carfilzomibIBA 01/2020 - 06/2012
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 11/2008
9	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 10/2005
9	Monoclonal AntibodiesIBA 01/2023 - 10/2006
9	Proteasome InhibitorsIBA 02/2017 - 02/2005
8	Factor VIII (Coagulation Factor VIII)IBA 04/2024 - 02/2011
7	brexucabtagene autoleucelIBA 02/2024 - 01/2020
7	AntibodiesIBA 07/2022 - 04/2008
7	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 10/2005
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 11/2006
7	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 11/2008
7	Thalidomide (Thalomid)FDA Link 08/2014 - 10/2003
6	AntigensIBA 09/2023 - 09/2007
6	zanubrutinibIBA 09/2023 - 01/2019
6	acalabrutinibIBA 07/2023 - 01/2018
6	venetoclaxIBA 01/2023 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 11/2013
4	BESIBA 05/2024 - 01/2022
4	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2024 - 01/2017
4	recombinant FVIIa (rFVIIa)FDA Link 07/2022 - 07/2013
4	axicabtagene ciloleucelIBA 01/2022 - 01/2020
4	Cyclin D1IBA 01/2019 - 02/2008
4	Prednisone (Sone)FDA LinkGeneric 01/2018 - 12/2013
4	Antineoplastic Agents (Antineoplastics)IBA 02/2017 - 05/2012
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016 - 07/2006
4	Melphalan (Alkeran)FDA LinkGeneric 05/2012 - 12/2008
3	VaccinesIBA 09/2023 - 10/2009
3	CytokinesIBA 01/2020 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 03/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2014
3	azaspiraneIBA 03/2012 - 06/2007
2	Valoctocogene RoxaparvovecIBA 04/2024 - 01/2023
2	AlbuminsIBA 01/2024 - 09/2014
2	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2023 - 12/2012
2	Phosphotransferases (Kinase)IBA 07/2023 - 11/2016
2	Hemostatics (Antihemorrhagics)IBA 07/2023 - 01/2017
2	von Willebrand FactorIBA 07/2023 - 01/2022
2	ChemokinesIBA 07/2023 - 10/2018
2	pirtobrutinibIBA 01/2023 - 01/2021
2	human F8 protein FDA Link 01/2023 - 08/2020
2	Neutralizing AntibodiesIBA 01/2023 - 11/2006
2	Factor VII (Proconvertin)IBA 07/2022 - 11/2021

Therapy/Procedure

83	Therapeutics 02/2024 - 02/2005
23	Drug Therapy (Chemotherapy) 01/2023 - 10/2004
9	Radiotherapy 05/2019 - 05/2007
8	Immunotherapy 11/2022 - 09/2007
6	Aftercare (After-Treatment) 01/2023 - 10/2005
6	Hematopoietic Stem Cell Transplantation 01/2016 - 12/2008
5	Stem Cell Transplantation 01/2023 - 09/2007
4	Decompression 12/2021 - 11/2010
4	Minimally Invasive Surgical Procedures 07/2019 - 10/2017
3	Transplantation 01/2023 - 11/2010
2	Re-Irradiation 07/2023 - 07/2023